• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia

Trendingnow

1

After 40 investors rejected Jeff Bezos’ Amazon pitch, his parents offered $245,573 of their retirement savings

2

China now makes up a record 40% of all global container exports—and it’s a sign Trump’s tariffs meant to punish Chinese firms have fallen flat

3

Billionaire Nike cofounder Phil Knight gives $1 billion to his alma mater: ‘This is no time to abandon’ higher education

1

After 40 investors rejected Jeff Bezos’ Amazon pitch, his parents offered $245,573 of their retirement savings

2

China now makes up a record 40% of all global container exports—and it’s a sign Trump’s tariffs meant to punish Chinese firms have fallen flat

3

Billionaire Nike cofounder Phil Knight gives $1 billion to his alma mater: ‘This is no time to abandon’ higher education

Venture capital deals

By
Dan Primack
Dan Primack
Down Arrow Button Icon
By
Dan Primack
Dan Primack
Down Arrow Button Icon
April 24, 2012, 1:51 PM ET
Google source logo
Add Fortune on Google for similar content.

Argos Therapeutics Inc., a Durham, N.C.-based developer of immunotherapies for the treatment of cancer and infectious diseases, has raised $25 million in Series D funding. Forbion Capital led the round, and was joined by fellow return backers like TVM Capital, Lumira Capital, Intersouth Partners, Caisse de dépôt et placement du Québec, Morningside Group and Aurora Funds. The company recently withdrew its IPO registration due to “market conditions,” and previously raised over $100 million in VC funding. www.argostherapeutics.com

MiRagen Therapeutics Inc., a Boulder, Colo.-based developer of microRNA-based therapeutics for the treatment of cardiovascular and muscle disease, has raised $20 million in Series B funding. Remeditex Ventures led the round, and was joined by return backers Atlas Venture, Boulder Ventures, Amgen Ventures and Broadview Ventures. www.miragenrx.com

Terascala Inc., an Avon, Mass.-based company that accelerates big data applications through storage I/O optimization, has raised $14 million in Series B funding. Undisclosed strategic backers were joined by existing investor Ascent Venture Partners. www.terascala.com

Singly, a San Francisco-based developer of a software platform and service for personal data, has raised around $6.5 million in VC funding led by Foundry Group. www.singly.com

Citrus Lane, a Mountain View, Calif.-based subscription delivery service for infant and toddler products, has raised $5.1 million in Series A funding from GGV Capital and seed backer Greylock Partners. www.citruslane.com

Locu, a Cambridge, Mass.-based data structuring startup, has raised $4 million in Series A funding. General Catalyst Partners led the round, and were joined by Lowercase Capital, Lightbank, SV Angel and return backers Quotidian Ventures, Matt Ocko, Naval Ravikant and Babak Nivi. www.locu.com

Oligomerix Inc., a New York–based developer of disease-modifying therapeutics for Alzheimer’s disease and related neurodegenerative disorders, has raised around $2 million in Series A funding (including debt conversion). Backers include Wheatley MedTech Partners, Wheatley New York Partners and Durand Venture Associates. www.oligomerix.com

Zauber, an Argentina-based software boutique and lab, has raised $1 million in first-round funding from AxVentures-Pymar Fund. www.zauberlabs.com

LED Engin Inc., a San Jose, Calif.-based solid-state lighting company, has raised an undisclosed amount of Series E funding. GVT Fund led the round, and was joined by MSIVC and return backers WK Technology Fund, Partech International and NGP Energy Technology Partners. www.ledengin.com

Want deal news in your inbox each morning? Get Term Sheet!

About the Author
By Dan Primack
See full bioRight Arrow Button Icon

Latest in


Most Popular

Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • TikTok icon
  • YouTube icon

    Latest in


    Most Popular

    © 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
    FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.